Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | AR | P10275 | 1/20 | 0.41 |
| ▸ | CRHBP | P24387 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10195636 | 0.90 | LMNA (0.42) | LOXL2KMT2ALMNASMN1; SMN2MEN1 | |
| SCHEMBL12786634 | 0.89 | GAA (0.42) | KMT2ALMNASMN1; SMN2MEN1HTT | |
| SCHEMBL13495621 | 0.88 | KMT2A (0.38) | LOXL2KMT2ALMNASMN1; SMN2MEN1 | |
| SCHEMBL23056749 | 0.77 | GFER (0.37) | LOXL2LMNASMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL16174713 | 0.77 | ELANE (0.44) | KMT2AHTTALDH1A1CYP2C19CYP1A2 | |
| SCHEMBL17171326 | 0.75 | MEN1 (0.39) | LOXL2KMT2ALMNASMN1; SMN2MEN1 | |
| SCHEMBL3091631 | 0.74 | GLA (0.61) | LOXL2KMT2ALMNAMEN1TSHR | |
| SCHEMBL1204527 | 0.72 | LOXL2 (0.48) | LOXL2LMNASMN1; SMN2KDM4ETSHR | |
| SCHEMBL8247259 | 0.72 | TSHR (0.46) | LOXL2KMT2ATSHRIDO1KCNJ1 | |
| SCHEMBL14788909 | 0.71 | KDM4E (0.61) | LOXL2KMT2ALMNASMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210061782-A1 | Diamine Compound with Meldrum's Acid Group and Related Polymer Thereof | NATIONAL TSING HUA UNIVERSITY (TW) | 2021-03-04 | — | — | US | disclosed |
| US-10208031-B2 | Photocrosslinkable materials comprising alicyclic group | ROLIC AG (CH) | 2019-02-19 | — | — | US | disclosed |
| US-10197881-B2 | Complimentary polymer electrochromic device | ASHWIN-USHAS CORPORATION, INC. (US) | 2019-02-05 | — | — | US | disclosed |
| US-20170362381-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | ROLIC AG (CH) | 2017-12-21 | — | — | US | disclosed |
| US-20170362381-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | ROLIC AG (CH) | 2017-12-21 | — | — | US | disclosed |
| US-20170184936-A1 | Complimentary Polymer Electrochromic Device | ASHWIN-USHAS CORP INC (US) | 2017-06-29 | — | — | US | disclosed |
| US-20170184936-A1 | Complimentary Polymer Electrochromic Device | ASHWIN-USHAS CORP INC (US) | 2017-06-29 | — | — | US | disclosed |
| EP-2780762-B1 | COMPLIMENTARY POLYMER ELECTROCHROMIC DEVICE | ASHWIN-USHAS CORP INC (US) | 2017-06-28 | — | — | EP | disclosed |
| EP-2780762-B1 | COMPLIMENTARY POLYMER ELECTROCHROMIC DEVICE | ASHWIN-USHAS CORP INC (US) | 2017-06-28 | — | — | EP | disclosed |
| US-9594284-B2 | Complimentary polymer electrochromic device | ASHWIN-USHAS CORPORATION, INC. (US) | 2017-03-14 | — | — | US | disclosed |
| US-20080293888-A1 | Photocrosslinkable Materials | ROLIC AG (CH) | 2008-11-27 | — | — | US | disclosed |
| WO-2008135131-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | ROLIC AG (CH) | 2008-11-13 | — | — | WO | disclosed |
| EP-1966119-A1 | PHOTOCROSSLINKABLE MATERIALS | Rolic AG (CH) | 2008-09-10 | — | — | EP | disclosed |
| EP-1860094-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2007-11-28 | — | — | EP | disclosed |
| WO-2007071091-A1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2007-06-28 | — | — | WO | disclosed |
| EP-1801097-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2007-06-27 | — | — | EP | disclosed |
| US-20050288480-A1 | Liquid crystals adjustment layers containing diamine compound; polyamic acid or polyimides; crosslinked | ROLIC AG (CH) | 2005-12-29 | — | — | US | disclosed |
| EP-1525182-A1 | PHOTOACTIVE MATERIALS | Rolic AG (CH) | 2005-04-27 | — | — | EP | disclosed |
| WO-2004013086-A1 | PHOTOACTIVE MATERIALS | ROLIC AG (CH) | 2004-02-12 | — | — | WO | disclosed |
| EP-1386910-A1 | Photoactive materials | Rolic AG (CH) | 2004-02-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10208031-B2 | Photocrosslinkable materials comprising alicyclic group | DDC, ALAD, DYNC1LI1 | LOXL2 1264/4885KMT2A 770/4885LMNA 590/4885 |
| US-20210061782-A1 | Diamine Compound with Meldrum's Acid Group and Related Polymer Thereof | DDC, DAO, TLR5 | LOXL2 1390/4885KMT2A 119/4885LMNA 3702/4885 |
| US-20080293888-A1 | Photocrosslinkable Materials | DDC, PARG, ALAD | LOXL2 2938/4885KMT2A 666/4885LMNA 2057/4885 |
| US-10197881-B2 | Complimentary polymer electrochromic device | PMS2, PARG, EED | LOXL2 653/4885KMT2A 692/4885LMNA 3263/4885 |
| US-20050288480-A1 | Liquid crystals adjustment layers containing diamine compound; polyamic acid or polyimides; crosslinked | C9, F12, DAO | LOXL2 1394/4885KMT2A 511/4885LMNA 581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.